Quarterly Operating Margin
-287.84%
+407.41%+58.60%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly operating profit margin is currently -287.84%, with the most recent change of +407.41% (+58.60%) on 30 September 2024. GLUE quarterly operating margin is now at all-time high.GLUE Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
GLUE Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +91.2% | ||
| 5 y | 5 years | at high | +91.2% | ||
| alltime | all time | at high | +91.2% |
Monte Rosa Therapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -287.84%(-58.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -695.25%(-78.8%) |
| Mar 2024 | - | -3284.49% |
FAQ
- What is Monte Rosa Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Monte Rosa Therapeutics?
What is Monte Rosa Therapeutics quarterly operating profit margin?
The current quarterly operating margin of GLUE is -287.84%
What is the all time high quarterly operating margin for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly operating profit margin is -287.84%